Skip Ribbon Commands
Skip to main content
Skip to main navigation Skip to main content
Sign In

Ongoing cases

  • AUTH/2990/11/17 - Voluntary admission from AbbVie
    Description:Failure to comply with examination requirements
    Case Status:Breach ruled, case report pending
    Last Updated:20/02/2018
  • AUTH/2988/10/17 - Employee v Otsuka
    Description:Manager’s use of LinkedIn to promote medicines
    Case Status:Breach ruled, case report pending
    Last Updated:23/02/2018
  • AUTH/2984/10/17 - Health Professional v Astellas UK
    Description:Promotion of Advagraf
    Case Status:Appeal by complainant
    Last Updated:22/01/2018
  • AUTH/2979/9/17 - Anonymous, non-contactable complainant v PharmaMar
    Description:Promotion of Yondelis
    Case Status:Breach ruled, Audit, Public reprimand, Corrective statement
    Last Updated:22/01/2018
  • AUTH/2978/9/17 - Anonymous consultant dermatologist v Janssen
    Description:Alleged Promotion of Tremfya
    Case Status:Appeal by respondent
    Last Updated:20/12/2017
  • AUTH/2969/8/17 - Senior Practice Nurse v AstraZeneca
    Description:Conduct of a representative
    Case Status:Breach ruled, case report pending
    Last Updated:23/02/2018
  • AUTH/2967/8/17 - Consultant v Shire
    Description:Omission of prescribing information and other obligatory information
    Case Status:No breach, outwith the scope of the Code
    Last Updated:11/12/2017
  • AUTH/2966/8/17 - Consultant v Takeda
    Description:Promotion of vedolizumab
    Case Status:No breach, outwith the scope of the Code
    Last Updated:11/12/2017
  • AUTH/2962/7/17 - Sales representative v Pierre Fabre
    Description:Call rates and certification of meetings
    Case Status:Breach ruled, case report pending, public reprimand
    Last Updated:02/02/2018
  • AUTH/2961/6/17 - Indivior v Martindale
    Description:Promotion of Espranor and information to the public
    Case Status:Breach ruled, case report pending
    Last Updated:22/01/2018
  • AUTH/2909/11/16 - Director v Astellas UK
    Description:Clinical trial disclosure (Xtandi)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2907/11/16 - Director v Takeda
    Description:Clinical trial disclosure (Vipidia)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2905/11/16 - Director v A Menarini
    Description:Clinical trial disclosure (Spedra)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2904/11/16 - Director v Lundbeck
    Description:Clinical trial disclosure (Selincro)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2900/11/16 and AUTH/2910/11/16 - Director v Sanofi
    Description:Clinical trial disclosure (Lyxumia) and (Zaltrap)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2899/11/16 - Director v Aegerion
    Description:Clinical trial disclosure (Lojuxta)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2896/11/16 - Director v Janssen
    Description:Clinical trial disclosure (Invokana)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2895/11/16 - Director v Boehringer Ingelheim
    Description:Clinical trial disclosure (Giotrif)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2894/11/16 - Director v Mitsubishi Tanabe
    Description:Clinical trial disclosure (BindRen)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2891/11/16 - Ex-employee v Astellas
    Description:Certification and review of materials
    Case Status:No breach, outwith the scope of the Code
    Last Updated:24/01/2017
  • AUTH/2881/10/16 - Anonymous, non-contactable v Shire
    Description:Alleged Shire video on a public website
    Case Status:No breach, outwith the scope of the Code
    Last Updated:22/11/2016
  • AUTH/2858/7/16 - Health Professional v Bayer
    Description:Alleged promotion to the public
    Case Status:No breach, outwith the scope of the Code
    Last Updated:12/10/2016